Adaptive Biotechnologies Corporation (ADPT) Net Income by Year
Adaptive Biotechnologies Corporation reported a net loss of $59.5M in fiscal year 2025. This represents an increase of 62.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $63.9M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Adaptive Biotechnologies Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADPT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ADPT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Adaptive Biotechnologies Corporation financials
Frequently Asked Questions
What was Adaptive Biotechnologies Corporation's net income in fiscal year 2025?
Adaptive Biotechnologies Corporation reported a net loss of $59.5M in fiscal year 2025.
How fast is Adaptive Biotechnologies Corporation's net income growing?
Adaptive Biotechnologies Corporation (ADPT) net income rose by 62.7% year over year, from -$159.5M to -$59.5M in fiscal year 2025.
What is Adaptive Biotechnologies Corporation's net income over the last twelve months?
Adaptive Biotechnologies Corporation (ADPT) reported a $63.9M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Adaptive Biotechnologies Corporation's net income changed over the years?
Across the 9 fiscal years this page covers, Adaptive Biotechnologies Corporation (ADPT) net income went from -$42.8M in fiscal year 2017 to -$59.5M in fiscal year 2025.
What was Adaptive Biotechnologies Corporation's net income in the most recent quarter?
Adaptive Biotechnologies Corporation (ADPT) reported -$39.8M in net income in Q2 2026. This represents a decrease of 55.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Adaptive Biotechnologies Corporation (ADPT) reported on that line in every period on record.